Breast Cancer Research & Therapies

Zhiqiang An is Professor of Molecular Medicine, the Robert A. Welch Distinguished University Chair in Chemistry, and Director of the Texas Therapeutics Institute at the UT Health Science Center at Houston. His laboratory focuses on breast cancer antibody drug resistance mechanisms and cancer antibody drug discovery Previously, he was Director of Biologics Research at Merck Research Laboratories. Dr. An received his Ph.D. degree from the University of Kentucky and his postdoctoral training at the University of Wisconsin-Madison. He is elected fellow of Society for Industrial Microbiology and Biotechnology (SIMB) and the American Academy of Microbiology (ASM).

Molecular Medicine

RAGHU S. PANDURANGI is the Founder, President & CSO: January 2012 to Current for Sci-Engi-Medco Solutions Inc. Engineering and Basic Science to Clinical Medicine in St Louis, USA and has 20 years of total scientific leadership in targeted drug development. Having Proven track record of directing and building strong multidisciplinary team (chemists, biologists, post doctoral fellows, technicians & students) for research and preclinical program, Led 2 Products for FDA/EMEA approval (analytics, CMCs for IND/NDA and taken 1 oligo based cancer therapeutic product from concept to Phase 1).

New cancer targets, Nanobiotechnology, Chemotherapy ,Radiation therapy, Targeted Therapy

Dr. D. Roukos has graduated from Athens University School of Medicine, Greece. He underwent specialist training in surgery at the J.W.Goethe-University Hospital in Frankfurt a.M., Germany where received his Doctorate (Dr.med). He moved back to Greece and since 1990 works at the Ioannina University School of Medicine.

Gastric Breast cancer,Nonlinear Experimentation, Next Generation Sequencing(NGS).

Dr. Constantine Dimitrakakis recieved his Ph.D. degree at National and Kapodistrian University of Athens and is currently an associate Professor Athens University Medical School, Athens, Greece. He has published (over 70 articles in PubMed Journals) mainly on the breast, laboratory and clinical studies on hormone therapy and breast cancer. Clinically based research on the role of androgens on breast cancer risk. Active member of the American Association of Cancer Research (AACR). Member of NIH FARE (fellow’s awards of research excellence) He is a Member of EUSOMA, EMAS, ESC and Greek Societies President of Greek Gynecologic Society of Breast Diseases (EGEPAM) Member of the Bioethics Committee of the Greek Ministry of Health Reviewer in noumerous scientific journals (The Breast, Journal of Clinical Endocrinology and Metabolism, BioMed Central journals etc.) Over 10 International Awards and numerous International Collaborations

Laboratory and clinically based breast research at the NIH, USA. Focus on the effects of Hormone Therapy on breast cancer risk and possible modifications of it.

The research in my laboratory is focused on understanding signaling networks within cells and how these signaling events modulate gene expression and proliferation. Extracellular signals are routed through signaling networks where they can activate multiple pathways, integrate at different levels, and form positive and negative feedback loops. The laboratory uses a combination of computational modeling and experimental biology to gain a systems understanding of the network and how it regulates gene expression and proliferation.

computational modeling to biochemical analysis of signaling events to proteomics using reverse phase high density lysate microarrays

Mufeed J. Ewadh has his expertise in many fields of biochemistry research in his institute dealing with health problem, herbal extraction, alternative medicine .He participated in many international and local conferences and workshops which deal with improvement of biochemical research to increase people awareness about its role. He participated in post doctorate course in Marburg University (Germany) on 2005 ,and he participated in electrophoresis workshop in japan for two weeks as well as in biochemical workshop in Leipzig (Germany) / 2016.His postgraduate supervision deals with many graduate students (M.Sc. and Ph.D.) which focus on publishing more than 140 papers in different local and international journals. His interest in publishing research paper made his institute to nominate him as the best professor for two years (2003),(2009) .He is chief in editor of most famous journal in Iraq (Medical Journal of Babylon ) and he got many rewards during his scientific life

Biochemistry

Dr. Kumar received his Ph.D. degree in Neuro-toxicology and is currently a Professor of Biochemistry at The Commonwealth Medical College, Scranton, PA, USA. Dr. Kumar’s research area is focused on the therapeutic targeting of the steroid receptors (SRs) for endocrine-related cancers. Currently, his laboratory is working on a novel therapeutic strategy that could provide cell/tissue-specific target gene regulations in current SHR-based endocrine therapies. In addition to more than 100 publications to his credit, Dr. Kumar has also served as Editorial Board member of more than two-dozen scientific journals, and as expert reviewer on more than two-dozen grant review panels.

Currently, his laboratory is working on a novel therapeutic strategy that could provide cell/tissue-specific target gene regulations in current SHR-based endocrine therapies.

Dr Ivan Terziev was born in 1961. He graduated in Medicine in 1987 from the Medical University of Sofia and obtained a specialty in Pathology and Cytology in 1991. Dr Terziev has been working at Tsaritsa Yoanna ISUL University Hospital since 1988, and he is also an Assistant professor of Pathology at the Medical University of Sofia, Bulgaria. Dr Terziev is a member of Bulgarian and European Society of Pathology and Bulgarian-Turkish group on Diseases of Thyroid and Breast. He has numerous publications in Bulgarian scientific journals, as well as more than 20 papers in reputed international ones. Dr Terziev is working in the area of histopathology of head of neck, thyroid gland, gastrointestinal, breast and surgical pathology

Dr Terziev’s research interests include diagnostic and immunohistochemical examination of rare tumors with different localization.

Prof. Kathy Qian Luo received BS, MS from Peking University and Ph.D. from the University of British Columbia in Canada. After finishing Postdoc research at California Institute of Technology in USA, she was working as a Visiting Assistant Professor in the Hong Kong University of Science and Technology and an Associate Professor in Nanyang Technological University of Singapore. Prof. Luo now is a Full Professor in the Faculty of Health Sciences at the University of Macau. She has published 70 journal articles with total citations of 2,000 and h-index of 25. She obtained 7 patents from USA, China, and Singapore.

•Cancer research: Identify driver proteins responsible for cancer cell survival in circulation, metastasis, and drug resistance. •Drug discovery: Discover new anti-cancer agents and elucidate their mechanisms of action. •Metabolic diseases: Study diabetes-related endothelial cell death and discover new biomarkers for diabetes diagnosis. •Aging: Generate transgenic zebrafish for studying apoptosis in neuronal and epithelial cells during aging process.

Dr.ABOUELNAGAH born in Alexandria, Egypt and did his Medical Studies at Alexandria University. He had Master Degree in Colorectal surgery 1993, FRCS Glasgow and FRCS Edinburgh 1999, Diploma in Laparoscopy from Europian Surgical Institute, Germany, August 2000, MD surgical oncology from Alexandria Univerisity, July 2003, MBA in hospital management:, February 2010 and lastly FRCS London, Sep 2010. In 1995 he worked as a senior registrar at Jeddah, Saudi Arabia, in 1996 he became assistant lecturer at Alexandria University Surgical Oncology Unit graded up as Lecturer in 2003, assistant Prof in 2008, Professor in 2013 and head of the unit from 2014 till now. He is member of Egyptian society of surgeons, society of laparoscopy and society of surgical oncologists. He has authored over 31 articles on surgery and 3 books on this topic.

surgical Oncology & laparoscopy

Dr.Mojtaba Mafi M.D., Medical Doctor/ Physician, Graduate of Tehran University, School of Medicine with honour. He completed graduation on Nutrition, Gastroenterology and Hepatology, Obesity treatment and diabetes approved by Medical Sciences University successfully. He is an associate of Iran Hepatitis Network and Gastroenterology and Hepatology research centre, Middle East Liver Diseases Center (MELD). He studied on fatty liver and related metabolic disorders among Iranian families from 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidaemia, diabetes and nutrition as study director and clinician associate member of Hepatitis Network. He is a reviewer of Hepatitis Monthly Journal and Journal of Clinical and Translational Hepatology. He passed successfully more than 10 courses with certificates in Iranian association of gastroenterology and hepatology. One of his works on diabetes and fatty liver as a scientific article has been accepted in 4th International Conference on Diabetes and Its Treatments at Dubai 2018 for oral presentation and publication. He is an organizing committee member and speaker of International Conference of Nutrition and Diet Imbalance, Indonesia, 2018. His article on fatty liver and metabolism has been accepted in International Conference on Gastroenterology and Hepatology, Thailand 2018, for oral and poster presentation. He have verified reviewer and certified mentor of Publons academy in the field of Clinical Medicine and Hepatology. He has been invited participant for International Conference of Translational Medicine, Hawaii, from the editor in chief of American Journal of Translational Medicine, and also invited speaker of International Conference on Obesity and Chronic diseases, 2018 in Dubai, he is organizing committee member of Cancer Science and Therapy Congress. Rome, Italy.

Hepatology, Liver Diseases, Gastroenterology, Neuro-Oncology